RBC Capital Keeps Their Buy Rating on Cormedix (CRMD)
In a report released on January 7, Gregory Renza from RBC Capital maintained a Buy rating on Cormedix (CRMD – Research Report), with a price ...
AMH price target lowered to $40 from $41 at RBC Capital
RBC Capital analyst Brad Heffern lowered the firm’s price target on AMH (AMH) to $40 from $41 and keeps an Outperform rating ...
Financial Services Roundup: Market Talk
Find insight on BBVA, Australia’s banks and more in the latest Market Talks covering Financial Services.
RBC Capital Sticks to Their Hold Rating for Moderna (MRNA)
In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
EconoTimes1d
RBC Upgrades Utilities Sector While Downgrading Energy
RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading ...
BMO stock gets 20% price target hike, upgrade to 'Outperform' from RBC
Mihelic hiked his price target on Toronto-listed BMO shares from $133 to $161, while upgrading his rating to “Outperform” ...
ca.investing.com on MSN2d
Carvana stock jumps as RBC lifts rating to Buy
RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270.
E&E1d
Exxon drops after warning of oil, refining hit to 4Q profit
Exxon Mobil’s shares fell after the company warned its fourth-quarter earnings will take a hit from lower crude prices and narrowing refining margins during the final three months of 2024.
RBC quantitative analyst makes 10 changes to his top 40 Canadian stock picks
Scotiabank analyst Mario Saric thinks the worst may be over for domestic office REITs, ...
RBC Capital Remains a Buy on Nasdaq (NDAQ)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Nasdaq (NDAQ – Research Report) yesterday and set a price target of $95.00. The ...